The aim of the course is to present the students with the most important aspects of clinical and epidemiological evaluation of a drug. The main topics covered during the course will be the experimental, legislative, ethical, clinical, economical and pharmaco-epidemiological aspects of drug discovery and use.
Expected learning outcomes
At the end of the course, the student will be able to follow the entire development of a new active compound or pharmaceutical formulation, to understand how to design a clinical study needed for marketing the new drug, and how to evaluate the results of this study from the clinical, pharmacoeconomical and pharmacoepidemiological points of view.
Lesson period: Second semester
(In case of multiple editions, please check the period, as it may vary)